Annual Drug Patent Expirations for ARISTADA
Aristada is a drug marketed by Alkermes Inc and is included in two NDAs. It is available from one supplier. There are fifteen patents protecting this drug.
Drug patent litigation for ARISTADA.
This drug has one hundred and six patent family members in twenty-seven countries.
The generic ingredient in ARISTADA is aripiprazole lauroxil. One supplier is listed for this compound. Additional details are available on the aripiprazole lauroxil profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
